UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 21, pp. 1994 - 2004
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | General aspects | Medical sciences | Platelet diseases and coagulopathies | Hemophilia B - therapy | Dependovirus - genetics | Gene Expression | Follow-Up Studies | Genetic Vectors - administration & dosage | Humans | Middle Aged | Hemophilia B - blood | Factor IX - genetics | Male | Alanine Transaminase - blood | Hemophilia B - genetics | Young Adult | Adult | Factor IX - metabolism | Infusions, Intravenous | Transgenes | Genetic Therapy - adverse effects | Physiological aspects | Hemophilia B | Research | Gene expression | Safety education | Analysis | Alanine | Intravenous administration | Toxicity | Genes | Body weight | Genomes | Patients | Clinical outcomes | Coagulation factors | Hemophilia | Alanine transaminase | Gene therapy | Prednisolone | Index Medicus | Abridged Index Medicus
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 04/2010, Volume 8, Issue 4, pp. 737 - 743
phenotype | hemophilia A | endogenous thrombin potential | hemophilia B | genotype | Genotype | Hemophilia B | Phenotype | Endogenous thrombin potential | Hemophilia A | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Predictive Value of Tests | Hemophilia B - diagnosis | Humans | Middle Aged | Case-Control Studies | Hemorrhage - etiology | Adult | Factor IX - metabolism | Hemophilia A - diagnosis | Odds Ratio | Severity of Illness Index | Genetic Predisposition to Disease | Hemorrhage - genetics | Risk Assessment | Gene Frequency | Risk Factors | Hemophilia B - blood | Factor VIII - genetics | Factor IX - genetics | Logistic Models | Hemorrhage - blood | Hemophilia B - genetics | Hemophilia A - blood | Hemophilia A - complications | Hemophilia B - complications | Blood Coagulation Tests | Blood Coagulation - genetics | Italy | Hemophilia A - genetics | Factor VIII - metabolism | Thrombin - metabolism | Genetic aspects | Blood coagulation factors | Analysis | Hemophilia | Index Medicus
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 11/2014, Volume 12, Issue 11, pp. 1935 - 1939
Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Hemophilia B - therapy | Severity of Illness Index | Hemarthrosis - diagnosis | Hemophilia B - classification | Predictive Value of Tests | Hemophilia B - diagnosis | Humans | Hemophilia B - blood | Terminology as Topic | Treatment Outcome | Hemophilia A - therapy | Hemophilia A - blood | Disease Progression | Hemarthrosis - blood | Hemarthrosis - classification | Coagulants - therapeutic use | Hemophilia A - classification | Hemarthrosis - therapy | Hemophilia A - diagnosis | Hemophilia | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 07/2015, Volume 13, Issue 7, pp. 1184 - 1195
genetic carrier detection | factor IX | prenatal diagnosis | DNA Mutational Analysis | hemophilia B | Hemophilia B | DNA mutational analysis | Factor IX | Genetic carrier detection | Prenatal diagnosis | Severity of Illness Index | Predictive Value of Tests | Genetic Predisposition to Disease | Hemophilia B - diagnosis | Prognosis | Humans | Prenatal Diagnosis | Risk Factors | Hemophilia B - blood | Factor IX - genetics | Hemostasis - genetics | Male | Hemophilia B - genetics | Phenotype | Animals | Sex Factors | Factor IX - metabolism | Female | Heterozygote | Mutation | Algorithms | Pregnant women | Analysis | Hemophilia | Genetic aspects | Nucleotide sequencing | Prothrombin complex concentrate | DNA sequencing | Index Medicus | Review
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 23, pp. 2215 - 2227
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hemophilia B - therapy | Genetic Vectors - administration & dosage | Factor IX - therapeutic use | Humans | Middle Aged | Dependovirus - immunology | Factor IX - genetics | Male | Hemorrhage - prevention & control | Hemophilia B - genetics | Young Adult | Adolescent | Adult | Factor IX - metabolism | Transgenes | Hemophilia B - metabolism | Genetic Therapy - methods | Usage | Genetic aspects | Research | Gene therapy | Genetic variation | Hemophilia | Coagulation factors | Liver | Body weight | Prophylaxis | Prednisone | Genomes | Drug dosages | Bleeding | Clotting | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 2018, Volume 131, Issue 9, pp. 1022 - 1031
Life Sciences & Biomedicine | Hematology | Science & Technology | Hemophilia B - therapy | Genetic Therapy | Prednisolone - administration & dosage | Humans | Hemophilia B - blood | Factor IX - genetics | Male | Hemophilia B - genetics | Adult | Female | Genetic Vectors | Factor IX - biosynthesis | Parvovirinae | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 819 - 828
Hemophilia B - therapy | Single-Blind Method | Humans | Middle Aged | Hemophilia B - blood | Male | Healthy Volunteers | Hemophilia A - therapy | Hemophilia A - blood | Dose-Response Relationship, Drug | Young Adult | Thrombin - biosynthesis | Antithrombin III - antagonists & inhibitors | Injections, Subcutaneous | Antithrombins - blood | Adult | RNAi Therapeutics | Care and treatment | Usage | Antithrombin III | Hemophilia | Hemophilia B | Research | Gene therapy | Plasma | Intravenous administration | Hematology | RNA-mediated interference | Liver | Body weight | Thrombin | Injection | Antithrombin | Clotting | Plasma levels | Alloantibodies | Thromboembolism | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 13, pp. 3038 - 3041
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Platelet diseases and coagulopathies | Hemophilia B - therapy | Severity of Illness Index | Dependovirus - genetics | Gene Transfer Techniques | Gene Expression | Genetic Vectors - administration & dosage | Humans | Factor IX - genetics | Male | Muscle, Skeletal - metabolism | Hemophilia B - genetics | Genetic Vectors - genetics | Dependovirus - physiology | Organ Specificity - genetics | Hemophilia B - pathology | Time Factors | Adult | Factor IX - metabolism | Muscle, Skeletal - pathology | Hemophilia B - metabolism | Genetic Therapy - methods | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis | Gene Therapy | Brief Report
Journal Article
Blood, ISSN 0006-4971, 01/2009, Volume 113, Issue 4, pp. 797 - 806
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Platelet diseases and coagulopathies | Hemophilia B - therapy | Dependovirus - genetics | Liver - metabolism | RNA, Messenger - genetics | Gene Expression Regulation | Factor IX - genetics | Tomography, X-Ray Computed | Hemophilia B - genetics | Genetic Vectors - genetics | Animals | Hemophilia B - pathology | Time Factors | Immune Tolerance - immunology | Dogs | Factor IX - metabolism | DNA, Viral - genetics | Hemophilia B - metabolism | Genetic Therapy - adverse effects | Index Medicus | Abridged Index Medicus | Gene Therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10040, pp. 187 - 197
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hemophilia B - therapy | Factor VIII - immunology | Genetic Therapy | Hemophilia B - diagnosis | Hemophilia B - immunology | Factor IX - immunology | Factor IX - therapeutic use | Hemorrhage - therapy | Hemophilia A - immunology | Humans | Hemorrhage - prevention & control | Hemophilia A - therapy | Coagulants - therapeutic use | Antibodies, Neutralizing - immunology | Early Medical Intervention | Coagulants - immunology | Hemophilia A - diagnosis | Factor VIII - therapeutic use | Complications and side effects | Medical colleges | Hemophilia | Prothrombin | Thrombin | Diagnosis | Plants | Genes | Medical treatment | Clinical trials | Mutation | Disease management | Medical diagnosis | Index Medicus | Abridged Index Medicus
Journal Article